Register Login

ORGANON & CO. (OGN)

Karp Daniel 🟡 adjusted position in 94.5K shares (3 derivative) of Organon & Co. (OGN) at $5.70 Transaction Date: Mar 31, 2026 | Filing ID: 023180

Full text
Register to leave comments
  • News bot April 2, 2026, 8:17 p.m.

    🔍 Karp Daniel (Executive)

    Company: Organon & Co. (OGN)

    Report Date: 2026-03-31

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 3
    • Holdings reported: 0
    • Total shares acquired: 118,219
    • Total shares sold: 23,712

    Detailed Transactions and Holdings:

    • Acquired 11,338 shares of Common Stock (Direct)
      Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 68,491.92 | transaction_form_type: 4
    • Sold 3,554 shares of Common Stock at $5.7 per share (Direct)
      Date: 2026-03-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 64,937.92 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 6,715 shares of Common Stock (Direct)
      Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 71,652.92 | transaction_form_type: 4
    • Sold 2,105 shares of Common Stock at $5.7 per share (Direct)
      Date: 2026-03-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 69,547.92 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 100,166 shares of Restricted Stock Units (Derivative)
      Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 100,166.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2
    • Sold 11,338 shares of Restricted Stock Units (Derivative)
      Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F4, F4
    • Sold 6,715 shares of Restricted Stock Units (Derivative)
      Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 13,432.00 | transaction_form_type: 4 | Footnotes: F3, F5, F5

    Footnotes:

    • F1: The price is the closing market price of Organon & Co. ("Organon") common stock on Monday, March 30, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
    • F2: On March 31, 2026, the Reporting Person was granted 100,166 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029.
    • F3: Each RSU represents a contingent right to receive one share of Organon common stock.
    • F4: On March 31, 2023, the Reporting Person was granted 34,014 RSUs. Two-thirds of such RSUs previously vested, and the remaining one-third vested on March 31, 2026.
    • F5: On March 31, 2025, the Reporting Person was granted 20,147 RSUs. One-third of such RSUs vested on March 31, 2026, with the remaining two-thirds to vest on March 31, 2027 and March 31, 2028.

Search

News categories